These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31403697)

  • 1. Transition from mesenchymal to bleb-based motility is predominantly exhibited by CD133-positive subpopulation of fibrosarcoma cells.
    Chikina AS; Rubtsova SN; Lomakina ME; Potashnikova DM; Vorobjev IA; Alexandrova AY
    Biol Cell; 2019 Oct; 111(10):245-261. PubMed ID: 31403697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics.
    Feng BH; Liu AG; Gu WG; Deng L; Cheng XG; Tong TJ; Zhang HZ
    Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actin cytoskeleton in mesenchymal-to-amoeboid transition of cancer cells.
    Alexandrova AY; Chikina AS; Svitkina TM
    Int Rev Cell Mol Biol; 2020; 356():197-256. PubMed ID: 33066874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actin cytoskeleton regulator Arp2/3 complex is required for DLL1 activating Notch1 signaling to maintain the stem cell phenotype of glioma initiating cells.
    Zhang C; Hai L; Zhu M; Yu S; Li T; Lin Y; Liu B; Zhou X; Chen L; Zhao P; Zhou H; Huang Y; Zhang K; Ren B; Yang X
    Oncotarget; 2017 May; 8(20):33353-33364. PubMed ID: 28380416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-resolved ultrastructure of the cortical actin cytoskeleton in dynamic membrane blebs.
    Chikina AS; Svitkina TM; Alexandrova AY
    J Cell Biol; 2019 Feb; 218(2):445-454. PubMed ID: 30541746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Met-induced membrane blebbing leads to amoeboid cell motility and invasion.
    Laser-Azogui A; Diamant-Levi T; Israeli S; Roytman Y; Tsarfaty I
    Oncogene; 2014 Apr; 33(14):1788-98. PubMed ID: 23665680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia Induces a HIF-1-Dependent Transition from Collective-to-Amoeboid Dissemination in Epithelial Cancer Cells.
    Lehmann S; Te Boekhorst V; Odenthal J; Bianchi R; van Helvert S; Ikenberg K; Ilina O; Stoma S; Xandry J; Jiang L; Grenman R; Rudin M; Friedl P
    Curr Biol; 2017 Feb; 27(3):392-400. PubMed ID: 28089517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway.
    Zhang L; Wang D; Li Y; Liu Y; Xie X; Wu Y; Zhou Y; Ren J; Zhang J; Zhu H; Su Z
    PLoS One; 2016; 11(8):e0158529. PubMed ID: 27505247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of CD133 overexpression on the epithelial-to-mesenchymal transition in oral cancer cell lines.
    Moon Y; Kim D; Sohn H; Lim W
    Clin Exp Metastasis; 2016 Jun; 33(5):487-96. PubMed ID: 27137188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Membrane Blebbing Is Controlled by Subcellular Distribution of Vimentin Intermediate Filaments.
    Chikina AS; Zholudeva AO; Lomakina ME; Kireev II; Dayal AA; Minin AA; Maurin M; Svitkina TM; Alexandrova AY
    Cells; 2024 Jan; 13(1):. PubMed ID: 38201309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The amoeboid state as part of the epithelial-to-mesenchymal transition programme.
    Graziani V; Rodriguez-Hernandez I; Maiques O; Sanz-Moreno V
    Trends Cell Biol; 2022 Mar; 32(3):228-242. PubMed ID: 34836782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RASSF1C oncogene elicits amoeboid invasion, cancer stemness, and extracellular vesicle release via a SRC/Rho axis.
    Tognoli ML; Vlahov N; Steenbeek S; Grawenda AM; Eyres M; Cano-Rodriguez D; Scrace S; Kartsonaki C; von Kriegsheim A; Willms E; Wood MJ; Rots MG; van Rheenen J; O'Neill E; Pankova D
    EMBO J; 2021 Oct; 40(20):e107680. PubMed ID: 34532864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial loss of actin nucleator actin-related protein 2/3 activity triggers blebbing in primary T lymphocytes.
    Obeidy P; Ju LA; Oehlers SH; Zulkhernain NS; Lee Q; Galeano Niño JL; Kwan RY; Tikoo S; Cavanagh LL; Mrass P; Cook AJ; Jackson SP; Biro M; Roediger B; Sixt M; Weninger W
    Immunol Cell Biol; 2020 Feb; 98(2):93-113. PubMed ID: 31698518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HERV-K activation is strictly required to sustain CD133+ melanoma cells with stemness features.
    Argaw-Denboba A; Balestrieri E; Serafino A; Cipriani C; Bucci I; Sorrentino R; Sciamanna I; Gambacurta A; Sinibaldi-Vallebona P; Matteucci C
    J Exp Clin Cancer Res; 2017 Jan; 36(1):20. PubMed ID: 28125999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquisition of tumorigenic potential and therapeutic resistance in CD133+ subpopulation of prostate cancer cells exhibiting stem-cell like characteristics.
    Kanwal R; Shukla S; Walker E; Gupta S
    Cancer Lett; 2018 Aug; 430():25-33. PubMed ID: 29775627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of Assembly of the Vimentin Intermediate Filaments Leads to Suppression of Formation and Maturation of Focal Contacts and Alteration of the Type of Cellular Protrusions.
    Zholudeva AO; Potapov NS; Kozlova EA; Lomakina ME; Alexandrova AY
    Biochemistry (Mosc); 2024 Jan; 89(1):184-195. PubMed ID: 38467554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An In Vitro System to Study the Mesenchymal-to-Amoeboid Transition.
    Chikina AS; Alexandrova AY
    Methods Mol Biol; 2018; 1749():21-27. PubMed ID: 29525987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6 promotes growth and epithelial-mesenchymal transition of CD133+ cells of non-small cell lung cancer.
    Lee SO; Yang X; Duan S; Tsai Y; Strojny LR; Keng P; Chen Y
    Oncotarget; 2016 Feb; 7(6):6626-38. PubMed ID: 26675547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells.
    Funasaka T; Hu H; Yanagawa T; Hogan V; Raz A
    Cancer Res; 2007 May; 67(9):4236-43. PubMed ID: 17483335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells.
    Navas T; Pfister TD; Colantonio S; Aziz A; Dieckman L; Saul RG; Kaczmarczyk J; Borgel S; Alcoser SY; Hollingshead MG; Lee YH; Bottaro DP; Hiltke T; Whiteley G; Takebe N; Kinders RJ; Parchment RE; Tomaszewski JE; Doroshow JH
    PLoS One; 2018; 13(6):e0199361. PubMed ID: 29928062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.